Varenicline can help smokers to stop smoking by gradual reduction

Evidence-Based Medicine

Volumn 20, Issue 4, 2015, Pages 133-

  Fagerstrom, Karl ^a  

^a Smoker's Information Centre   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

HUMAN; INSOMNIA; MOTIVATION; NAUSEA; NOTE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SMOKING; SMOKING CESSATION; FEMALE; MALE; PROCEDURES; TOBACCO USE DISORDER;

BENZAZEPINES; FEMALE; HUMANS; MALE; NICOTINIC AGONISTS; QUINOXALINES; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84938923967     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebmed-2015-110199     Document Type: Note

References (3)

1. Fagerstrom K. Can reduced smoking be a way for smokers not interested in quitting to actually quit? Respiration 2005;72:216-20.
2. Lindson-Hawley N, Aveyard P, Hughes J. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev 2012;11:CD008033. http://dx.doi.org/10.1002/14651858.CD008033.pub3. http://online library.wiley.com/doi/10. 1002/14651858.CD008033.pub3/abstract
3. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012;4:CD006103.